Tylenol is owned and produced by Kenvue Inc., a consumer health company that was spun off from Johnson & Johnson in 2023. Kenvue is a publicly traded company headquartered in Summit, New Jersey, and owns several well-known consumer brands including Tylenol. The company operates independently from Johnson & Johnson since the spin-off and holds the stock for Tylenol among other consumer health products.